The effect of the Covid-19 pandemic on the body composition of patients with gastroenteropancreatic neuroendocrine tumors using a somatostatin analogue

#4186

Introduction: The Covid-19 pandemic and its restrictions had a negative impact on the general population. Due to lockdowns, food intake increased and exercise decreased. This led to weight gain and changes in body composition. Hospitals reviewed patients (pts) remotely. The effect of the Covid-19 pandemic has not been described in pts with gastroenteropancreatic neuroendocrine tumors (GEP-NETs) treated with somatostatin analogue (SSA).

Aim(s): To explore the effect of the Covid-19 pandemic and remote review on the body composition in pts with GEP-NETs treated with SSA.

Materials and methods: Pts with GEP-NETs treated with SSA who had a pre-pandemic CT-scan (Aug 2018 – Feb 2019) and CT scan during the pandemic (Jan 2021 – July 2021) were included. Body composition analysis were performed using a single slice CT-scan at lumbar level L3. Muscle area (expressed as cm2/m2), muscle quality (expressed as Hounsefield Units, HU) fat area (expressed as cm2) were analysed.

Conference:

Presenting Author: Clement D

Authors: Clement D, Brown S, Dolly S, Mestre-Alagarda C, Giovos G,

Keywords: GEP-NET, SSA, malnutrition, Covid-19 pandemic,